MEDS TRxADE HEALTH Inc: Total Debt to Equity Ratio
TRxADE HEALTH, Inc. (MEDS) is undergoing a profound business model transformation, shifting from niche pharmacy software toward new logistics verticals, which has temporarily destabilized its financial reporting. Simultaneously, the business is developing cloud-based B2B solutions incorporating AI analytics and telemedicine. This price chart on GURU.Markets captures the metric at 0.00. Their transparent procurement system, which minimizes pharmacy costs, enjoys high trust among small medical businesses.
Metric breakdowns and analytics for TRxADE Health Corp (MEDS)
The development of the TRxADE HEALTH (MEDS) B2B marketplace requires a balance between attracting independent pharmacies and managing borrowed funds. This ratio compares total liabilities to equity, determining the company's degree of dependence on creditors while scaling procurement agreements. By analyzing the company's leverage history, an investor can assess the risk of bankruptcy or, conversely, the untapped potential of financial leverage for expansion.